290 related articles for article (PubMed ID: 35582046)
1. Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions.
Juric V; Murphy B
Cancer Drug Resist; 2020; 3(1):48-62. PubMed ID: 35582046
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer.
Ding L; Cao J; Lin W; Chen H; Xiong X; Ao H; Yu M; Lin J; Cui Q
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183020
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
4. Targeting Cyclin-Dependent Kinases in Ovarian Cancer.
Zhou Q
Cancer Invest; 2017 Jul; 35(6):367-376. PubMed ID: 28406716
[TBL] [Abstract][Full Text] [Related]
5. The evolution of cyclin dependent kinase inhibitors in the treatment of cancer.
Jhaveri K; Burris Rd HA; Yap TA; Hamilton E; Rugo HS; Goldman JW; Dann S; Liu F; Wong GY; Krupka H; Shapiro GI
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1105-1124. PubMed ID: 34176404
[No Abstract] [Full Text] [Related]
6. Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies.
Baghdassarian N; Ffrench M
Hematol Cell Ther; 1996 Aug; 38(4):313-23. PubMed ID: 8891723
[TBL] [Abstract][Full Text] [Related]
7. Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway.
Shen S; Dean DC; Yu Z; Duan Z
Hepatol Res; 2019 Oct; 49(10):1097-1108. PubMed ID: 31009153
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
Ravitz MJ; Wenner CE
Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
Roskoski R
Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase pathways as targets for women's cancer treatment.
Konecny GE
Curr Opin Obstet Gynecol; 2016 Feb; 28(1):42-8. PubMed ID: 26642065
[TBL] [Abstract][Full Text] [Related]
11. Negative regulators of cyclin-dependent kinases and their roles in cancers.
Lee MH; Yang HY
Cell Mol Life Sci; 2001 Nov; 58(12-13):1907-22. PubMed ID: 11766887
[TBL] [Abstract][Full Text] [Related]
12. Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.
Spring LM; Zangardi ML; Moy B; Bardia A
Oncologist; 2017 Sep; 22(9):1039-1048. PubMed ID: 28706010
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitors in yeast, animals, and plants: a functional comparison.
De Clercq A; Inzé D
Crit Rev Biochem Mol Biol; 2006; 41(5):293-313. PubMed ID: 16911957
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase inhibitors for the treatment of lung cancer.
Qin A; Reddy HG; Weinberg FD; Kalemkerian GP
Expert Opin Pharmacother; 2020 Jun; 21(8):941-952. PubMed ID: 32164461
[TBL] [Abstract][Full Text] [Related]
15. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
[TBL] [Abstract][Full Text] [Related]
16. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
17. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.
Chou J; Quigley DA; Robinson TM; Feng FY; Ashworth A
Cancer Discov; 2020 Mar; 10(3):351-370. PubMed ID: 32071145
[TBL] [Abstract][Full Text] [Related]
18. A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib.
Chong QY; Kok ZH; Bui NL; Xiang X; Wong AL; Yong WP; Sethi G; Lobie PE; Wang L; Goh BC
Pharmacol Res; 2020 Jun; 156():104686. PubMed ID: 32068118
[TBL] [Abstract][Full Text] [Related]
19. Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System.
Grison A; Atanasoski S
Mol Neurobiol; 2020 Jul; 57(7):3206-3218. PubMed ID: 32506380
[TBL] [Abstract][Full Text] [Related]
20. Cyclin dependent kinase inhibitors.
Harper JW
Cancer Surv; 1997; 29():91-107. PubMed ID: 9338098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
